News Conference News ESC 2025 Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD L.A. McKeown September 05, 2025
News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
News Daily News REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD L.A. McKeown January 24, 2023
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News ACC 2022 No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3 Michael O'Riordan April 13, 2022
News Conference News ESC 2021 FFR During Angiogram Not Beneficial in Chest Pain Patients: RIPCORD 2 Michael O'Riordan August 29, 2021
News Conference News SCAI 2020 Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA Caitlin E. Cox May 20, 2020
News Conference News TCT 2019 ‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures L.A. McKeown September 28, 2019
News Conference News EuroPCR 2018 ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics Michael O'Riordan May 31, 2018
News Conference News SCAI 2018 PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI L.A. McKeown April 26, 2018
News Conference News TCT 2017 No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy Michael O'Riordan October 30, 2017
News Daily News In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year Yael L. Maxwell July 31, 2015
Presentation Relationship Between Stent Type and QoL Following PCI for Acute MI Presenter: Adnan K. Chhatriwalla July 30, 2015
News Daily News Un Registro Belga Confirma una Supervivencia Similar a los 3 Años con las Válvulas Sapien y CoreValve en la realización de TAVR Transfemorales Yael L. Maxwell June 03, 2015